博世科(300422) - 2019 Q3 - 季度财报

Financial Performance - Operating revenue for the period reached CNY 908,554,401.87, representing a 22.23% increase year-on-year[9] - Net profit attributable to shareholders increased by 48.68% to CNY 102,454,262.67 for the quarter[9] - Basic earnings per share rose by 52.63% to CNY 0.29, while diluted earnings per share increased by 47.37% to CNY 0.28[9] - The company reported a net profit of CNY 243,769,405.81 for the year-to-date, up 39.24% from the previous year[9] - The company's total operating revenue for the current period reached ¥2,428,189,746.16, an increase of 28.4% compared to ¥1,891,765,545.87 in the previous period[66] - Net profit for the current period was ¥108,895,593.90, compared to ¥55,618,724.36 in the previous period, representing a significant increase of 95.7%[64] - The total comprehensive income for the current period was ¥108,895,593.90, compared to ¥55,618,724.36, showing an increase of 95.7%[65] Assets and Liabilities - Total assets increased by 31.62% to CNY 8,589,145,269.04 compared to the end of the previous year[9] - The total liabilities as of September 30, 2019, were CNY 6,635,040,335.73, compared to CNY 4,806,231,963.19 at the end of 2018, indicating a growth of 38.1%[53] - The company's total assets reached CNY 8,589,145,269.04, an increase of 31.5% from CNY 6,525,506,046.43 in the previous year[53] - The total current assets amounted to CNY 3,840,468,724.67, an increase of 32.5% compared to CNY 2,901,483,404.38 on December 31, 2018[51] - The company's total liabilities reached ¥4,806,231,963.19, with current liabilities at ¥2,965,376,829.50[79] Shareholder Information - The total number of shareholders at the end of the reporting period was 24,760[15] - The largest shareholder, Wang Shuangfei, holds 21.28% of the shares, amounting to 75,705,752 shares[15] - The top 10 shareholders did not engage in any repurchase transactions during the reporting period, indicating stable shareholder confidence[18] - The company has not reported any changes in the number of preferred shareholders, maintaining stability in its capital structure[19] Cash Flow and Financing - Cash inflow from operating activities totaled ¥1,385,155,826.57, compared to ¥1,152,803,919.67 in the previous period, showing a growth of 20.2%[72] - The company reported a net cash outflow of 95,830,869.56 yuan in the current period, contrasting with a net inflow of 228,793,810.28 yuan previously[73] - The company received 1,009,347,338.53 yuan from borrowings, a decrease from 1,135,992,000.00 yuan in the previous period, indicating a decline of approximately 11.1%[76] Operational Highlights - Research and development expenses rose by 75.36% to CNY 108,595,048.67, reflecting the company's intensified efforts in new product development[28] - The company signed new contracts worth 25.19 billion RMB during the reporting period, with 19.77 billion RMB attributed to EPC and EP contracts, including 10.40 billion RMB for water pollution treatment[41] - The company has optimized its order structure, focusing on short payment cycle contracts, which ensures reliable cash flow[41] Accounting and Compliance - The company has not made any adjustments to previous years' financial data due to accounting policy changes[9] - There were no significant accounting errors to correct as of the report date[10] - The company has implemented new financial accounting standards effective from January 1, 2019, which may affect future financial reporting[80]